A Phase 3 Prospective Multiventer Randomized Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution Delivered via the PARI Investigational eFLOW Device Plus SOC versus SOC in the Treatment of